Nektar Therapeutics (NKTR) Receivables - Net (2016 - 2025)
Nektar Therapeutics (NKTR) has 16 years of Receivables - Net data on record, last reported at $200000.0 in Q3 2025.
- For Q3 2025, Receivables - Net changed N/A year-over-year to $200000.0; the TTM value through Sep 2025 reached $200000.0, changed N/A, while the annual FY2023 figure was $1.2 million, 79.85% down from the prior year.
- Receivables - Net reached $200000.0 in Q3 2025 per NKTR's latest filing, down from $1.2 million in the prior quarter.
- Across five years, Receivables - Net topped out at $30.2 million in Q1 2022 and bottomed at $200000.0 in Q3 2025.
- Average Receivables - Net over 5 years is $12.0 million, with a median of $6.0 million recorded in 2022.
- Peak YoY movement for Receivables - Net: plummeted 90.09% in 2023, then rose 20.77% in 2024.
- A 5-year view of Receivables - Net shows it stood at $22.5 million in 2021, then crashed by 73.41% to $6.0 million in 2022, then plummeted by 79.85% to $1.2 million in 2023, then dropped by 0.75% to $1.2 million in 2024, then plummeted by 83.28% to $200000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $200000.0 in Q3 2025, $1.2 million in Q2 2024, and $3.6 million in Q1 2024.